No takes yet. Share an insight, caveat, or question.
Experimental analysis reveals benzothiazole derivatives reduce NF-κB and COX-2, suggesting therapeutic potential against HCC.
Üremi̇ş et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: